Purple Biotech Updates Investors on CAPTN-3 Platform and Pipeline as IM1240 Nears 2027 Clinic EntryTip Ranks·Jun 23 at 09:49 AMPPBT-4.86%
U.S. stock night market fluctuations: Aplite rose 3.10% with net inflow from main funds, and biotech stocks slightly increasedPrice Alert·Jun 12 at 02:46 AMPPBT-4.86%
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga_article·Jun 11 at 12:05 PMGELS-11.20%ADIL+4.98%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Jun 11 at 07:05 AMPPCB-8.33%PPBT-4.86%
Purple Biotech shares are trading higher after the company announced the presentation of new preclinical data from its lead CAPTN-3 program, IM1240, at EACR 2026 Annual Congress.benzinga_article·Jun 11 at 06:17 AMPPBT-4.86%
Purple Biotech Q1 2026 Results Highlight CAPTN-3 Pivot and IM1240 Preclinical MomentumTip Ranks·May 15 at 06:28 AMPPBT-4.86%
Purple Biotech Reports First Quarter 2026 Financial Results and Business Highlights | PPBT Stock NewsStockTitan·May 14 at 10:00 PMPPBT-4.86%
Pre-market hot trades in US stocks: Purple Biotech up 7.23% in pre-market; Abits up 7.17% in pre-marketPrice Alert·Apr 20 at 04:32 AMPPBT-4.86%ABTS-1.71%
Patent Cliff Risk: How Expiring Protections Threaten Purple Biotech’s Future Exclusivity and ReturnsTip Ranks·Mar 20 at 01:01 AMPPBT-4.86%
US Stock Movement Update: Arcellx surged 77.55%, Signing Day Sports rose 54.44%, Blue Hat Interactive Ent Tech fell 46.28%Price Alert·Feb 23 at 01:00 PMACLX0.00%SGN0.00%
U.S. Stock Market Movement Update: Tech stocks are active, Rackspace Tech rises 9.52%, Moolec Science plummets 8.77%Price Alert·Feb 23 at 01:00 AMRXT-1.30%MLEC-1.33%
U.S. stock night market fluctuations: Purple Biotech rose 7.35% in night trading, with clear capital flow. Can market sentiment be sustained?Price Alert·Feb 22 at 08:36 PMPPBT-4.86%
